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The kidney transplant program at Hospital do Rim (hrim) is a unique healthcare 
model that applies the same principles of repetition of processes used in industrial 
production. This model, devised by Frederick Taylor, is founded on principles of 
scientific management that involve planning, rational execution of work, and dis-
tribution of responsibilities. The expected result is increased efficiency, improvement 
of results and optimization of resources. This model, almost completely subsidized 
by the Unified Health System (SUS, in the Portuguese acronym), has been used at 
the hrim in more than 11,000 transplants over the last 18 years. The hrim model 
consists of eight interconnected modules: organ procurement organization, prep-
aration for the transplant, admission for transplant, surgical procedure, post-op-
erative period, outpatient clinic, support units, and coordination and quality 
control. The flow of medical activities enables organized and systematic care of all 
patients. The improvement of the activities in each module is constant, with full 
monitoring of various administrative, health care, and performance indicators. The 
continuous improvement in clinical results confirms the efficiency of the program. 
Between 1998 and 2015, an increase was noted in graft survival (77.4 vs. 90.4%, 
p<0.001) and patient survival (90.5 vs. 95.1%, p=0.001). The high productivity, ef-
ficiency, and progressive improvement of the results obtained with this model 
suggest that it could be applied to other therapeutic areas that require large-scale 
care, preserving the humanistic characteristic of providing health care activity.
Keywords: kidney transplantation, tissue and organ procurement, renal insuf-
ficiency, Unified Health System.
introduction
Brazil, one of the few countries with universal health 
coverage established in its Federal Constitution and pro-
vided by the Unified Health System (SUS),1 has developed 
health care models that exceed the expectations of a de-
veloping country. Health programs that include nation-
wide vaccination, treatment of patients infected with the 
HIV virus, and organ transplants are examples of inter-
national significance.2
Brazil has the second largest national transplant 
program, second only to the United States. Every year 
around 8,000 solid organ transplants are performed, 
5,556 of which are kidney transplants,3 with more than 
90% under the SUS system, making it the world’s largest 
public program in this therapeutic area. The regulation 
of the program and coordination of the procurement 
and distribution of organs are carried out by the Na-
tional Transplant System (SNT), a public service created 
in 1997, and put into operation by the Notification, Pro-
curement and Organ Distribution Centers (CNCDO) and 
Organ Procurement Organizations (OPO) established in 
the 27 State Departments of Health.
Hospital do Rim (hrim), one of the main players in 
this system, began a unique medical care model in 1998, 
aimed at conducting at least one kidney transplant per 
day.4 As such, it has been perfecting this model using con-
cepts from the systematic repetition of processes, as applied 
in industrial production and published in 1911 by Fred-
erick Taylor in his book The principles of scientific management, 
which is still poorly applied in healthcare. These principles 
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involve scientific planning, rational and broken-down ex-
ecution of the work, and the distribution of roles and re-
sponsibilities based on each personal development. The 
goal of this process is greater production, quality and sys-
tematic attainment of established goals. In this model the 
patient passes through specialized health care modules 
until the post-transplant period, when they are preferably 
treated by a single physician. As a consequence of this 
model, the annual number of transplants has gradually 
grown over this 18-year period, with over 850 kidney trans-
plants conducted annually since 2009 (Figure 1).5 These 
results have made the hrim the largest international kidney 
transplant center, treating patients from all regions of 
Brazil and, similar to what is done in the national transplant 
program, more than 90% of these activities are performed 
through the SUS.6 In this article, we describe this medical 
model in detail and the results obtained over the last 18 
years, aware that it could be applied in other clinical situ-
ations of health assistance, as well as in other regions.
prograM structure
The hrim, administered by the Oswaldo Ramos Foundation, 
has 151 hospital beds, with 16 in the intensive care unit, 
six in the immediate post-operative unit and nine in a day 
hospital unit. The surgical center offers four rooms and 
six beds for post-anesthetic recovery. All of the physicians 
employed by the hospital completed a medical residency 
in their respective specialty, and most of them are involved 
in graduate programs. The application of the large-scale 
production concepts is monitored weekly through analysis 
of the main clinical and administrative indicators, enabling 
early correction of deviations or distortions.7
Module A: Organ Procurement Organization (OPO)
In the regions of Greater São Paulo and Baixada Santista, 
with 21,000,000 inhabitants, the entire organ donation 
process is coordinated by four OPOs. The OPO at Escola 
Paulista de Medicina (OPO-EPM), administered by the 
Oswaldo Ramos Foundation, operates in a region of 
6,000,000 inhabitants, with 75 hospitals in the Greater 
São Paulo and Baixada Santista. The team is made up of 
two coordinators, that is, a nephrologist and a nurse, along-
side ten nurses divided into daily shifts and a team of 
surgeons dedicated to kidney extraction. This team carries 
out extensive supplementary activity to spread and con-
solidate the culture of organ donation in society, including 
the promotion of educational and training courses for 
physicians and hospital coordinators, in addition to rou-
tine visits to hospitals in the region.8
Module B: Preparation for the transplant
Registration, clinical assessments, and preparation of 
candidates for kidney transplants with living or deceased 
donors are carried out in this module, including simul-
taneous pancreas and kidney transplant candidates. Af-
ter a first contact, which may be by telephone or e-mail, 
the first evaluation is scheduled within a maximum of 
2 weeks. The service is carried out daily and conducted 
by a multidisciplinary team that includes nephrologists, 
surgeons, cardiologists, and a social worker. The risks 
and benefits of the transplant are discussed with poten-
tial donors and recipients.
Registration and preparation for the transplant with 
a living kidney donor includes the identification of the 
donor based on clinical criteria and blood and genetic 
compatibility, according to SNT regulations. All of the 
tests required for assessment of donor and recipient as 
well as evaluations with specialists are scheduled and 
carried out at the hrim, thereby avoiding difficulties and 
inefficiencies in the scheduling of laboratory tests and 
medical evaluations at several clinics. The steps involved 
in preparing the patient for the transplant are controlled 
using algorithms, preventing unnecessary delays, until 
the date of the transplant is scheduled.
The registration of transplant candidates with a 
deceased donor involves a clinical and laboratory assess-
ment, including serologic tests for communicable dis-
eases. Registration on the waiting list is based on blood 
type (ABO). During this evaluation, genetic typing of 
the candidate’s HLA system is scheduled at the immu-
nogenetics laboratory, which advises them to store a 
serum sample every 3 months for the completion of cross-
matching (antibodies against the donor’s HLA system 
in the serum of the recipient). Clinical reassessment and 
reorientation of the candidates are conducted annually, 
with complementary tests repeated according to clinical 
recommendations.
Module C: Admission for transplant
For transplants with kidney from a living donor, both the 
recipient and the donor are admitted on the eve of surgery, 
with clinical reassessment and a detailed review of all 
laboratory and genetic compatibility tests. Routine pre-
operative tests for surgery of medium complexity are car-
ried out. The risks and benefits of organ transplantation 
are discussed with the donor and the recipient again, fol-
lowed by the signing of a consent form for donation and 
transplantation. The surgery is elective, and normally 
carried out early in the morning on the following day. 
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For kidney transplants from deceased donor, the iden-
tification of potential recipient is conducted by the State 
Department of Health and is based primarily on the ABO 
blood type identity and higher compatibility with the 
donor’s HLA genetic system from among all active candi-
dates on the waiting list. Candidates identified and regis-
tered at our transplant center are then contacted by phone 
using a structured interview to assess their current medi-
cal conditions. Based on this interview, the potential can-
didate is invited to immediately undergo preoperative tests 
and clinical examinations. Once the recipient is defined, 
the risks and benefits of organ transplantation are once 
again discussed before signing a consent form to perform 
the transplant. The average time between the identification 
of the candidate and admission to the operating room is 
around 20 hours.
Module D: Surgical procedure
The surgical team is composed of eight urologists and 
two urology residents per year, divided into set teams 
from Monday to Friday and on-call shifts on weekends. 
The duration of the kidney transplant surgery varies from 
90 to 120 minutes, while nephrectomy of a living donor 
varies between 60 to 90 minutes. General anesthesia is 
applied to both the donor and the recipient. Donor ne-
phrectomy is performed through an anterior lumbotomy 
incision, and on the recipient is performed using a mod-
ified Gibson incision with vascular anastomosis to the 
iliac vessels and the ureter on the bladder according to 
the Gregoir or Politano-Leadbetter technique. The im-
plantation of ureteral catheters and drainage of the renal 
area are not performed routinely.9 For deceased donors, 
both kidneys are removed en bloc, most often associated 
with the removal of the abdominal or thoracic organs, 
with participation of multiple teams.
Module E: Post-operative period
After surgery, the donors and recipients are maintained 
in the immediate post-operative unit, where they remain 
for the first 18 to 24 hours. During this period, they are 
under the care of a specialized team that monitors clini-
cal and surgical complications in addition to initiating 
treatment with immunosuppressants according to pre-
determined protocols.  
Patients are conducted, from admission to discharge, 
at one of the four units with 30 beds, each of which man-
aged by two of the hospital’s physicians, divided into 
6-hour shifts, in addition to night and on-call physicians. 
All clinical and surgical activity is coordinated by one 
nephrologist and one urologist, with the routine clinical 
support of three infectious disease doctors, two cardiolo-
gists, and two pathologists. Daily visits and hospital dis-
charge are multidisciplinary with subsequent automatic 
scheduling of the first evaluation at the outpatient unit. 
Module F: Outpatient clinic
The outpatient department includes ten consulting rooms, 
three nursing stations, and an emergency room, while 
management is coordinated by a senior nephrologist. 
Coordination of clinical care is performed by two experi-
enced nephrologists, one in the morning and another in 
the afternoon. The health care flow is linear, starting with 
a nursing evaluation and followed by medical, pharma-
ceutical, psychological, and social work services, and end-
ing with the scheduling of the following evaluation and 
obtainment of the necessary documentation for the dis-
pense of medication at public pharmacies. 
The evaluations follow a predetermined schedule, 
the frequency of which is higher in the first months and 
then quarterly a year after the first year of transplant. 
Laboratory tests can be performed in the morning, with 
results available on the same day. Daily attendance is 
performed by a specialized medical team, with an aver-
age of 16 patients per 5-hour shift per physician. The 
coordinators guide the majority of evaluations, espe-
cially when they involve changes in conduct or immu-
nosuppression regimen. Patients who have health insur-
ance can follow a similar flow, or can be forward for 
monitoring with their referring physician. Few patients 
are monitored solely by their referring nephrologists, 
even when they live in other states. Elective hospital 
readmissions are coordinated directly by the outpatient 
department. Emergency care is provided at the hospital 
emergency unit.
Module G: Support units
The model has complete care provided by independent 
support units: (1) dialysis treatment unit; (2) day hospital 
unit; (3) immunogenetics laboratory; (4) clinical pathol-
ogy laboratory; (5) hospital infection control committee 
(CCIH); (6) diagnostic imaging unit; (7) urological inves-
tigation and intervention unit; (8) interventional cardiol-
ogy unit; (9) renal pathology unit.
The immunogenetics laboratory (IGEN) performs 
all of the genetic tests on patients registered for trans-
plantation at the hrim. The clinical laboratory, diagnos-
tic imaging, and renal pathology units provide diagnos-
tic support 24 hours a day.  In addition to the 
determination of the blood concentration of various 
immunosuppressive drugs, the clinical laboratory con-
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ducts all of the routine tests, and releases the final results 
on the same day as collection. Biological samples are 
taken by two groups of technicians, with capacity to 
attend up to ten patients simultaneously. The day hos-
pital has nine beds for less complex procedures, such as 
kidney biopsies, and 16 stations for outpatient intrave-
nous drug administration. Units for dialysis treatment, 
urological investigation and intervention, and cardiol-
ogy provide diagnostic and therapeutic support both 
before and after the transplant. Lastly, in addition to 
promoting and monitoring hospital infection control 
measures, with special attention to multiresistant bac-
teria, the hospital infection control committee also works 
on advising patients, family members and employees 
about the behavior and prevention of epidemics such as 
dengue fever and influenza, which are a greater risk for 
transplant patients.
Module H: Coordination and quality control
Consists of a systematic meeting designed to be the first 
morning activity on the first day of the week (Monday, 
at 7:30 am to 8:30 am) involving the leaders of the mod-
ules described above and members of the senior manage-
ment, with the aim of monitoring the performance of 
each module, benchmarking, and improvement of pro-
cesses. This activity is aimed at the most thorough, close 
and personal cooperation between participants, with 
equitable division of the work and responsibilities among 
the leaders for maximum performance, applying the 
concepts of scientific management through the presen-
tation of indicators. Leading and management activities 
are directed towards coordinated work with their groups 
of collaborators, disseminating the indicators of results, 
and seeking maximum individual and collective prosper-
ity, considering that even tasks with systematic repetition 
must be reviewed for permanent improvement. 
prograM outcoMes
Increase in the number of deceased donors
The number of brain death notifications by hospitals 
in the region of the OPO-EPM increased from 196 in 
1999 to 684 in 2015. The number of effective donors 
(potential donors whose organs were actually donated 
and transplanted) increased from 43 to 202 in the same 
period. The efficiency of the process is characterized by 
the reduction in the percentage of family refusal of 
donation, falling from 78 to 43%, and the increase in 
the donation effectiveness in the same period, from 22 
to 29% (Table 1). 
TABLE 1 Comparison of productivity indicators in 1999 
and 2015.
Productivity indicators 1999 2015
Effective deceased donors 43 202
Patients on the waiting list for transplant with 
kidneys from deceased donors
3,050 5,303
Total transplants 394 886
Adult with kidney from a living donor 271 205
Adult with kidney from a deceased donor 96 617
Pediatric with kidney from a living donor 22 4
Pediatric with kidney from a deceased donor 5 44
Simultaneous pancreas-kidney transplants 0 16
Cumulative number of transplants 503 12,724
Cumulative number of transplant recipients 
under monitoring
439 7,751
Number of evaluations at the outpatient department 7,295 59,781
Increase in the number of transplants
Between August 18, 1998 and December 31, 2015, 11,707 
transplants were conducted at hrim, with 10,580 kidney 
transplants in adults, 856 pediatric kidney transplants and 
271 simultaneous pancreas and kidney transplants. Over 
this 18-year period, the annual number of transplants has 
increased more than twice, from 394 in 1999 to 886 in 
2015 (Figure 1). Linear growth was observed between 1999 
and 2008, a period in which kidney transplants from liv-
ing donors predominated. Between 2009 and 2015 the 
number of transplants has remained relatively stable at 
856 to 919, but with a predominance of kidney transplants 
from deceased donors (76%). The same phenomenon was 
observed with pediatric transplants, with an increase of 27 
to 74 transplants between 1999 and 2009, and subsequent 
stabilization and predominance of kidney transplants from 
deceased donors (Figure 1). Finally, the number of simul-
taneous kidney and pancreas transplants remains relative-
ly stable at around 30 per year, with a decrease last year fol-
lowing an international trend, possibly justified by 
advances in pharmacological and glycemic control, as well 
as improved methods for the administration of insulin.
Currently, the hrim has 5,303 candidates registered on 
the kidney transplant waiting list and 338 for the combined 
pancreas and kidney transplant, which corresponds to 50% 
of the total number of candidates from the city of São 
Paulo registered on the single list (11,149) of the Health 
Secretariat (Table 1). The number of evaluations held for 
registration or annual reassessment of transplant candidates 
using a kidney from a deceased donor was 5,926 in 2015. 
In 2015, the number of registrations for performing kidney 
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transplants from a living donor was 436, and the average 
time of the donor and recipient until the transplant was 
scheduled was 12 days. In 2015, 886 transplants were car-
ried out at the hrim, including 617 from deceased donors, 
205 from living donors, 48 pediatric transplants, and 16 
kidney and pancreas transplants.
Quality control
Healthcare quality indicators are analyzed weekly. The 
global surgical complication rate directly related to the 
transplant procedure remains stable at around 6.5%, most 
of which are restricted to the surgical wound, and respon-
sible for graft loss in 1.1% of transplants. The surgical 
technique currently used reduces or even eliminates any 
objective advantage of laparoscopic nephrectomy of the 
donor, the cost of which is significantly higher.  
The average hospital stay is 8.2 days for recipients of a 
kidney from living donors and 12.5 days with kidneys from 
deceased donors. The early hospital readmission rate (less 
than 30 days after hospital discharge after the transplant), 
an indicator increasingly used by health insurers, is 26.6%. 
Between 2005 and 2015, reductions were noted in the 
infection rates of the surgical site (6.3 vs. 2.5%), urinary 
tract infection (18.1 vs. 4.4%) and ventilation-associated 
pneumonia (25 vs. 0.4 per 1,000 cases of mechanical ven-
tilation/day). On the other hand, there was a fluctuation 
in the rate of bloodstream infections, with 5.5 cases per 
1,000 central venous catheters per day in 2005, 13.4 in 
2007, and 2.6 in 2009. In 2015, the rate was 8.3 cases per 
1,000/day, similar to other institutions, and probably 
associated with the increased incidence of infections 
caused by multiresistant bacteria (Figure 2).
Performance of the support units
In the period between 2003 and 2015, the immunogenet-
ics laboratory increased the number of HLA system typing 
(4,203 to 4,374), sensitization tests for detection of anti-
-HLA antibodies in the serum (8,720 to 13,216), and cross-
-matching (5,670 to 14,577). The number of laboratory 
tests conducted by the laboratory increased 4.8 times 
between 1999 and 2015. In 2015, the number of tests 
conducted was 1,097,329, including determinations of 
the plasma and blood concentrations of immunosuppres-
sive drugs. At the day hospital unit, an average of six bi-
opsies of transplanted kidneys were conducted per day 
to investigate specific causes of dysfunction, as well as 
treating an average of five patients per day for outpatient 
treatment of infections, anemia and episodes of rejection 
of the transplanted kidney. The pathology lab processed 
and issued reports for 551 kidney biopsies on deceased 
donors and 2,500 on transplanted kidneys. The hemody-
namic service, which also serves the general population, 
conducted 2,033 diagnostic coronary angiograms, 524 
angioplasties with and without implantation of stents, 
as well as 49 angioplasties for treating stenosis of the 
artery of the transplanted kidney.
Efficiency in monitoring after the transplant
At the end of 2015, the number of patients being moni-
tored at the post-transplant unit was 7,751 (Table 1). In 
FIGURE 1 Annual number of transplants carried out at Hospital do Rim from August 18, 1998 to December 31, 2015, stratified by type of 
transplant: deceased, living, pediatric, and pancreas-kidney. 
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the same year, 59,781 medical evaluations were conduct-
ed, meaning an average of 237 daily evaluations.
Improvement of the survival results
The performance of a kidney transplant center is classi-
cally evaluated by graft survival, calculated as the percent-
age of transplant patients who complete the first year 
with the functioning kidney, stratified by the type of do-
nor, living or deceased. It has been noted that cumulative 
graft survival in the first year for transplants from 1998 
to 2002 was 89.2%, while for transplants from 2011–2014, 
graft survival was 92.5%. Graft survival in transplants 
with living donors increased from 93.9% in 1998–2002 to 
97.2% in 2011–2014, and from 77.4 to 90.4% with deceased 
donors (Figure 3). Similarly, the survival of patients in 
transplants from a living donor increased from 97.8% in 
1998–2002 to 98.7% in 2011–2014, and from 90.5 to 95.1% 
with deceased donors. Sixty percent (60%) of the 5,189 
patients undergoing kidney transplants from deceased 
donors between 1998 and 2014 completed one year after 
transplant with graft function considered as excellent 
(creatinine less than 1.5 mg/dL). This proportion was 66% 
for the 5,377 recipients of kidney transplants from living 
donors conducted in the same period. 
In relation to the 11,436 kidney transplants carried 
out between 1998 and 2015, 68% of patients are under 
monitoring, 12% lost graft function and returned to di-
alysis treatment, 12% died and 8% were transferred or no 
longer monitored at our unit. The most frequent cause 
of death was infection (53%), followed by cardiovascular 
complications (16%).
Education and Research Program
The large number of transplants conducted annually has 
enabled participation in national and international multi-
center clinical studies, which are also important for identi-
fying the best immunosuppressive regime in different types 
of patients, taking into account that the demographic char-
acteristics of the Brazilian population differ from American 
and European populations. Between 1998 and 2015, over 
3,000 patients were included in more than 60 phase I to IV 
clinical studies, contributing significantly to the adoption 
of new forms of immunosuppression by the regulatory 
agencies in the United States, Europe, and Brazil. Treatment 
strategies being investigated and validated at the hrim are 
subsequently adopted by various transplant centers in Bra-
zil and abroad. In parallel, a training and education program 
in clinical research for pharmacists has been developed, 
involving 83 students that subsequently entered the labor 
market, whether in pharmaceutical industries, private com-
panies or academic clinical research centers.
The growth of research and education activities led to 
the creation of the Education and Research Center (NEP, 
in the Portuguese acronym) in 2014. Between 1998 and 
2015, 1,276 physicians, including 1,176 from Brazil and 
100 from other countries, mainly in Latin America, par-
ticipated in medical education activities at the hrim. In 
2015, 364 undergraduate students, 49 residents (nephrol-
FIGURE 2 Indicators from the Hospital Infection Control Committee during the period from 2005 to 2015 for urinary tract infection, 
bloodstream infection, surgical site infection, and pneumonia associated with ventilation.
UTI: urinary tract infection; TX: transplant; BSI: bloodstream infection; ICU: intensive care unit; SSI: surgical site infection; VAP: ventilation-associated pneumonia; cvc: central venous catheter; 
mv: mechanical ventilation.
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ogy, urology, cardiology, infectious diseases, multidisci-
plinary, and pharmacy) and 136 interns were trained. In 
the same year, 17 scientific studies were conducted, includ-
ing four doctoral dissertations and 13 master’s degree 
theses, as well as 15 articles published in indexed journals 
and 75 papers presented at national and international 
conferences. At the national level, this model of continuing 
education has led to the creation of new transplant centers 
in several states and increased activity at existing centers. 
discussion
The hrim’s transplant model is based on maximum spe-
cialization, systematic repetition, and improvement of 
processes by all of the professionals involved in each of its 
modules. This model, which has enabled a significant in-
crease in the number of transplants performed, has also 
provided academic and healthcare training for profes-
sionals dedicated to this therapeutic area throughout the 
national territory, also including the country in the interna-
tional context of clinical research in the area.10 On two oc-
casions, it has received approval by the Food and Drug Ad-
ministration (FDA) as well as several hospital quality 
certifications, including national accreditation with excel-
lence (Level 3) from the National Accreditation Organiza-
tion (ONA), teaching hospital certification from the Minis-
try of Education and Culture and the Ministry of Health.
The efficiency and interconnection of the modules 
has influenced all of the performance metrics. In 1998, 
75% of transplants were performed with kidneys from live 
donors, while from 2009 on the number of transplants 
with kidneys from deceased donors increased, reaching 
76% of transplants performed in 2015.11,12 The growth in 
the number of deceased donors, as well as the marked 
progress in dialysis assistance, has enabled us to apply 
more stringent criteria for kidney transplants from living 
donors. These restrictions are based on surgical risk (mor-
tality rate after kidney donation at 3 per 10,000), and 
uncertainty about the risks of developing chronic kidney 
disease in the long-term, considering the progressive in-
crease in the life expectancy of the general population.
The largest share of revenues is the result of remu-
neration for healthcare production by the SUS (62%) as 
well as supplementary health providers. A small fraction 
comes from clinical research activities or the obtainment 
of additional public funds. The remuneration of the 
medical team is variable depending on the intensity of 
their participation in the program. The production, ad-
ministrative, and financial indicators are subject to month-
ly external audits and presented semiannually to the board 
of trustees and the Public Ministry through its trustee of 
foundations. This hierarchy of controls demands perma-
nent administrative rigor, but the budget balance of the 
service to the SUS depends on surplus revenue from the 
service to patients treated under supplementary medicine 
and, to a lesser extent, from additional public funds.
perspectives
The transplant model performed at the hrim results in 
increased productivity, efficiency, and progressive improve-
ment of outcomes. This model can be applied in other 
medical intervention methods whose prevalence requires 
a large-scale care, such as the treatment of benign pros-
FIGURE 3 A. 12-month graft survival in recipients of kidney transplants from living donors in the period from 1998 to 2014. B. 12-month 
graft survival in recipients of kidney transplants from deceased donors in the period from 1998 to 2014.
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tatic hypertrophy, nephrolithiasis, ophthalmologic dis-
orders, several types of cancer, implantation of orthope-
dic prostheses, and myocardial revascularization. 
In our view, the greatest benefit of using this model 
could occur in developing countries, with limited avail-
ability of high complexity treatments for highly prevalent 
diseases. In these regions, the implementation of this model, 
even when restricted to a single institution, could offer ef-
fective treatments on a large scale for the majority of the 
population. Whatever the scenario, the application of this 
model for increased efficiency requires the principles of 
scientific management, introduced by Frederick Taylor and 
universally refined, to be incorporated and continuously 
enhanced by all the members of the institution.
resuMo
Um modelo pioneiro de aplicação dos conceitos da pro-
dução em larga escala na assistência à saúde: princípios 
e desempenho em mais de 11 mil transplantes no Hos-
pital do Rim
O programa de transplante renal do Hospital do Rim 
(hrim) é um modelo único de assistência médica que 
aplica os princípios da repetição de processos utilizados 
na produção industrial. Esse modelo, idealizado por Fre-
derick Taylor, é fundamentado em princípios da admi-
nistração científica, que envolvem planejamento, execução 
racional do trabalho e distribuição de responsabilidades. 
O resultado esperado é o aumento da eficiência, melhoria 
dos resultados e otimização de recursos. Esse modelo, 
quase todo subsidiado pelo Sistema Único de Saúde (SUS), 
foi utilizado no hrim para a realização de mais de 11 mil 
transplantes nos últimos 18 anos. O modelo do hrim 
consiste em oito módulos interconectados: organização 
de procura de órgãos, preparo para o transplante, admis-
são para transplante, procedimento cirúrgico, pós-ope-
ratório, seguimento pós-transplante, unidades de apoio, 
e coordenação e controle de qualidade. O fluxo das ativi-
dades médicas permite o atendimento organizado e sis-
temático de todos os pacientes. O aperfeiçoamento das 
atividades de cada módulo é constante, com monitora-
mento integral de diversos indicadores administrativos, 
assistenciais e de desempenho. A melhora contínua dos 
resultados clínicos confirma a eficiência do programa. 
Entre 1998 e 2015, foi observado um aumento nas sobre-
vidas do enxerto (77,4 vs. 90,4%; p<0,001) e do paciente 
(90,5% vs. 95,1%; p=0,001), respectivamente. A elevada 
produtividade, a eficiência e a melhoria progressiva dos 
resultados obtidos sugerem que esse modelo pode ser 
aplicado em outras áreas terapêuticas que necessitam de 
assistência em larga escala, sem comprometer os concei-
tos humanísticos de nossa atividade assistencial.
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